Open Beta
MetriLume

US marketsWVE

SEC-sourced researchBeta

WVE

Wave Life Sciences, Inc.

Company comparison ↗

Data passport

CIK
0001631574
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 113,305,000.0000 USD; December 2024: 108,302,000.0000 USD; December 2025: 42,727,000.0000 USD113.3M USD0 USD0December 2023December 2024December 2025
WVE · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023113,305,000.0000Feb 26, 2026
December 2024108,302,000.0000Feb 26, 2026
December 202542,727,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202542,727,000.0000-204,378,000.0000-187,493,000.0000638,499,000.0000112,268,000.0000Feb 26, 2026
December 2024108,302,000.0000-97,008,000.0000-151,026,000.0000352,207,000.0000134,818,000.0000Feb 26, 2026
December 2023113,305,000.0000-57,513,000.0000-19,431,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$42.73MDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$108.3MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$204.38MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$187.49MDecember 2025Feb 26, 202610-K
Total assetsAssets$638.5MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$112.27MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗